Radiotracer promises Parkinson's diagnosis:
This article was originally published in Clinica
A new technique which could be useful both as a diagnostic test for early, subclinical Parkinson's disease and for monitoring neuroprotective agents was described at the September European Neuroscience meeting in Amsterdam. Dr R Innis of Yale University (US) reported on a new radiotracer - (123)I-CIT - which labels dopamine transporters and can be imaged with single photon emission computed tomography (SPECT).
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
While analysts are struggling to look further than generic competition facing the French firm's best-seller Somatuline, new chief David Loew tells Scrip that intelligent lifecycle management and focused external deals will drive Ipsen's growth.
Bridges Consumer Healthcare launched by former Sanofi executives gets its first brand by acquiring North American rights to Pfizer’s ThermaCare HeatWraps brand. Pfizer divested the brand so European regulators would give antitrust clearance to its consumer JV with GSK.